 Helicobacter pylori
"Helicobacter pylori" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).
| Descriptor ID |
D016480
|
| MeSH Number(s) |
B03.440.500.550 B03.660.150.280.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Helicobacter pylori".
Below are MeSH descriptors whose meaning is more specific than "Helicobacter pylori".
This graph shows the total number of publications written about "Helicobacter pylori" by people in this website by year, and whether "Helicobacter pylori" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 2 | 0 | 2 | | 1991 | 6 | 0 | 6 | | 1992 | 3 | 1 | 4 | | 1993 | 4 | 2 | 6 | | 1994 | 6 | 1 | 7 | | 1995 | 10 | 1 | 11 | | 1996 | 20 | 2 | 22 | | 1997 | 19 | 1 | 20 | | 1998 | 20 | 0 | 20 | | 1999 | 25 | 3 | 28 | | 2000 | 29 | 3 | 32 | | 2001 | 16 | 4 | 20 | | 2002 | 39 | 4 | 43 | | 2003 | 40 | 8 | 48 | | 2004 | 24 | 7 | 31 | | 2005 | 32 | 8 | 40 | | 2006 | 26 | 6 | 32 | | 2007 | 22 | 6 | 28 | | 2008 | 34 | 7 | 41 | | 2009 | 37 | 8 | 45 | | 2010 | 33 | 9 | 42 | | 2011 | 31 | 11 | 42 | | 2012 | 27 | 6 | 33 | | 2013 | 27 | 7 | 34 | | 2014 | 34 | 5 | 39 | | 2015 | 33 | 5 | 38 | | 2016 | 24 | 4 | 28 | | 2017 | 32 | 5 | 37 | | 2018 | 32 | 11 | 43 | | 2019 | 17 | 5 | 22 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Helicobacter pylori" by people in Profiles.
-
Sonnenberg A, Turner KO, Genta RM. Low Prevalence of Helicobacter pylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in the United States. Am J Gastroenterol. 2020 02; 115(2):244-250.
-
Ono T, Cruz M, Jiménez Abreu JA, Nagashima H, Subsomwong P, Hosking C, Shiota S, Suzuki R, Yamaoka Y. Comparative study between Helicobacter pylori and host human genetics in the Dominican Republic. BMC Evol Biol. 2019 11 01; 19(1):197.
-
Khien VV, Thang DM, Hai TM, Duat NQ, Khanh PH, Ha DT, Binh TT, Dung HDQ, Trang TTH, Yamaoka Y. Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam. Gut Liver. 2019 09 15; 13(5):483-497.
-
Dore MP, Bibbò S, Loria M, Salis R, Manca A, Pes GM, Graham DY. Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies. Helicobacter. 2019 Dec; 24(6):e12659.
-
Tan MC, Graham DY. Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020. Gastrointest Endosc. 2019 09; 90(3):457-460.
-
Hanyu H, Engevik KA, Matthis AL, Ottemann KM, Montrose MH, Aihara E. Helicobacter pylori Uses the TlpB Receptor To Sense Sites of Gastric Injury. Infect Immun. 2019 09; 87(9).
-
Graham DY, Dang BN, El-Serag HB. Helicobacter pylori Infection. N Engl J Med. 2019 08 08; 381(6):587-588.
-
Lu H, Graham DY. Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment-authors' reply. Aliment Pharmacol Ther. 2019 08; 50(3):332.
-
Thrift AP, Kramer JR, Hartman CM, Royse K, Richardson P, Dong Y, Raychaudhury S, Desiderio R, Sanchez D, Anandasabapathy S, White DL, Chiao EY. Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):e65-e72.
-
Yu L, Luo L, Long X, Liang X, Ji Y, Graham DY, Lu H. High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial. Helicobacter. 2019 Aug; 24(4):e12596.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|